Hong Kong stocks launch a counterattack! The HSI technology index surged nearly 4%, what happened?
Today, the Asia-Pacific market remains weak, but the A-share and Hong Kong stock markets show relatively strong performance.
China's assets are booming! Institutions: Market sentiment indicators have dropped to a low level, with Hong Kong stocks still having room to rise.
Gtja pointed out that in the past week, the three major indices of Hong Kong stocks continued to decline in valuation, among which the valuation of the Hang Seng Technology Index decreased more significantly, but the southbound capital continued to maintain a net inflow. Considering the subsequent improvement in overseas liquidity coupled with the intensification of domestic policies, there is still room for Hong Kong's stock market.
Hong Kong Market Quick Review | The Hong Kong stocks surged in the afternoon! The technology index rose over 3.6%; sectors such as network technology stocks and semiconductors saw a strong rally, with Meituan rising over 7% and shanghai fudan increasing o
Network technology stocks rose, Meituan-W rose by 7.24%, jd.com Group-SW rose by 5.01%; biotechnology stocks generally rose, Kexin Botai Biotechnology-B rose by 10.11%, Keji Pharmaceutical-B rose by 7.73%; securities and brokerage stocks rose across the board, China Merchants Securities rose by 7.00%, Everbright Securities rose by 5.91%.
Express News | The hang seng index has increased by 1%, and the hang seng tech index has risen by 1.4%.
Hong Kong stocks midday review | Hong Kong stocks rebounded in a "V-shape", the technology index rose nearly 1%; biomedical, AI application stocks rose, Beigene rose nearly 4%, iCarbonX surged nearly 11%
Network technology stocks rose, with Meituan-W up 2.43% and jd.com-SW up 2.28%; biotechnology stocks all increased, with Kexing Pharmaceuticals-B up 9.48% and Junshi Biosciences up 4.29%; dining stocks generally declined, with super hi up 3.77% and yum china down 3.17%.
Hong Kong stock midday review | The hang seng index rose 0.42% in the morning, with most pharmaceutical stocks trending upwards.
The results of the medical insurance negotiation are about to be announced. Institutions point out that the sector still has further room for repair.